These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 28806457)

  • 1. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes.
    de Kovel CGF; Syrbe S; Brilstra EH; Verbeek N; Kerr B; Dubbs H; Bayat A; Desai S; Naidu S; Srivastava S; Cagaylan H; Yis U; Saunders C; Rook M; Plugge S; Muhle H; Afawi Z; Klein KM; Jayaraman V; Rajagopalan R; Goldberg E; Marsh E; Kessler S; Bergqvist C; Conlin LK; Krok BL; Thiffault I; Pendziwiat M; Helbig I; Polster T; Borggraefe I; Lemke JR; van den Boogaardt MJ; Møller RS; Koeleman BPC
    JAMA Neurol; 2017 Oct; 74(10):1228-1236. PubMed ID: 28806457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.
    Bar C; Barcia G; Jennesson M; Le Guyader G; Schneider A; Mignot C; Lesca G; Breuillard D; Montomoli M; Keren B; Doummar D; Billette de Villemeur T; Afenjar A; Marey I; Gerard M; Isnard H; Poisson A; Dupont S; Berquin P; Meyer P; Genevieve D; De Saint Martin A; El Chehadeh S; Chelly J; Guët A; Scalais E; Dorison N; Myers CT; Mefford HC; Howell KB; Marini C; Freeman JL; Nica A; Terrone G; Sekhara T; Lebre AS; Odent S; Sadleir LG; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Hum Mutat; 2020 Jan; 41(1):69-80. PubMed ID: 31513310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo KCNB1 mutations in infantile epilepsy inhibit repetitive neuronal firing.
    Saitsu H; Akita T; Tohyama J; Goldberg-Stern H; Kobayashi Y; Cohen R; Kato M; Ohba C; Miyatake S; Tsurusaki Y; Nakashima M; Miyake N; Fukuda A; Matsumoto N
    Sci Rep; 2015 Oct; 5():15199. PubMed ID: 26477325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
    Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant.
    Hawkins NA; Misra SN; Jurado M; Kang SK; Vierra NC; Nguyen K; Wren L; George AL; Trimmer JS; Kearney JA
    Neurobiol Dis; 2021 Jan; 147():105141. PubMed ID: 33132203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo KCNB1 mutations in epileptic encephalopathy.
    Torkamani A; Bersell K; Jorge BS; Bjork RL; Friedman JR; Bloss CS; Cohen J; Gupta S; Naidu S; Vanoye CG; George AL; Kearney JA
    Ann Neurol; 2014 Oct; 76(4):529-540. PubMed ID: 25164438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel KCNB1 mutation associated with non-syndromic intellectual disability.
    Latypova X; Matsumoto N; Vinceslas-Muller C; Bézieau S; Isidor B; Miyake N
    J Hum Genet; 2017 Apr; 62(5):569-573. PubMed ID: 27928161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of K
    Kang SK; Vanoye CG; Misra SN; Echevarria DM; Calhoun JD; O'Connor JB; Fabre KL; McKnight D; Demmer L; Goldenberg P; Grote LE; Thiffault I; Saunders C; Strauss KA; Torkamani A; van der Smagt J; van Gassen K; Carson RP; Diaz J; Leon E; Jacher JE; Hannibal MC; Litwin J; Friedman NR; Schreiber A; Lynch B; Poduri A; Marsh ED; Goldberg EM; Millichap JJ; George AL; Kearney JA
    Ann Neurol; 2019 Dec; 86(6):899-912. PubMed ID: 31600826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel mutation in KCNB1 gene in a child with neuropsychiatric comorbidities with both intellectual disability and epilepsy and review of literature].
    Miao P; Peng J; Chen C; Gai N; Yin F
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):115-119. PubMed ID: 28173649
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel de novo KCNB1 variant altering channel characteristics in a patient with periventricular heterotopia, abnormal corpus callosum, and mild seizure outcome.
    Hiraide T; Akita T; Uematsu K; Miyamoto S; Nakashima M; Sasaki M; Fukuda A; Kato M; Saitsu H
    J Hum Genet; 2023 Jan; 68(1):25-31. PubMed ID: 36257979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.
    Thiffault I; Speca DJ; Austin DC; Cobb MM; Eum KS; Safina NP; Grote L; Farrow EG; Miller N; Soden S; Kingsmore SF; Trimmer JS; Saunders CJ; Sack JT
    J Gen Physiol; 2015 Nov; 146(5):399-410. PubMed ID: 26503721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant.
    Kang SK; Hawkins NA; Thompson CH; Baker EM; Echevarria-Cooper DM; Barse L; Thenstedt T; Dixon CJ; Speakes N; George AL; Kearney JA
    Neurobiol Dis; 2024 May; 194():106470. PubMed ID: 38485094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.
    Kreienkamp HJ; Wagner M; Weigand H; McConkie-Rossell A; McDonald M; Keren B; Mignot C; Gauthier J; Soucy JF; Michaud JL; Dumas M; Smith R; Löbel U; Hempel M; Kubisch C; Denecke J; Campeau PM; Bain JM; Lessel D
    Hum Genet; 2022 Feb; 141(2):257-272. PubMed ID: 34907471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
    MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
    Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
    Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A
    Veale EL; Golluscio A; Grand K; Graham JM; Mathie A
    Front Pharmacol; 2022; 13():1093313. PubMed ID: 36618935
    [No Abstract]   [Full Text] [Related]  

  • 18. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
    Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
    Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy.
    Parenti I; Lehalle D; Nava C; Torti E; Leitão E; Person R; Mizuguchi T; Matsumoto N; Kato M; Nakamura K; de Man SA; Cope H; Shashi V; ; Friedman J; Joset P; Steindl K; Rauch A; Muffels I; van Hasselt PM; Petit F; Smol T; Le Guyader G; Bilan F; Sorlin A; Vitobello A; Philippe C; van de Laar IMBH; van Slegtenhorst MA; Campeau PM; Au PYB; Nakashima M; Saitsu H; Yamamoto T; Nomura Y; Louie RJ; Lyons MJ; Dobson A; Plomp AS; Motazacker MM; Kaiser FJ; Timberlake AT; Fuchs SA; Depienne C; Mignot C
    Hum Genet; 2021 Jul; 140(7):1109-1120. PubMed ID: 33944996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variability of the clinical expression of KCNB1 encephalopathy].
    Púa-Torrejón RC; González-Alguacil E; Soto-Insuga V; Moreno-Cantero T; Ortiz-Cabrera NV; Pérez-Poyato MS; Ruiz Falcó-Rojas ML; García-Peñas JJ
    Rev Neurol; 2021 Nov; 73(12):403-408. PubMed ID: 34877642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.